Navigation Links
AEterna Zentaris Receives US$10 Million from Institutional Investors
Date:6/24/2009

fer to buy any of AEterna Zentaris' common shares or warrants. No offer, solicitation or sale will be made in any jurisdiction in which such offer, solicitation or sale is unlawful.

Rodman & Renshaw, LLC, a subsidiary of Rodman & Renshaw Capital Group, Inc., (Nasdaq: RODM), acted as the exclusive placement agent for the transaction.

About AEterna Zentaris Inc.

AEterna Zentaris Inc. is a global biopharmaceutical company focused on endocrine therapy and oncology, with proven expertise in drug discovery, development and commercialization. News releases and additional information are available at www.aezsinc.com.

Forward-Looking Statements

This press release contains forward-looking statements made pursuant to the safe harbor provisions of the U.S. Securities Litigation Reform Act of 1995. Forward-looking statements involve known and unknown risks and uncertainties, which could cause the Company's actual results to differ materially from those in the forward-looking statements. Such risks and uncertainties include, among others, the availability of funds and resources to pursue R&D projects, the successful and timely completion of clinical studies, the ability of the Company to take advantage of business opportunities in the pharmaceutical industry, uncertainties related to the regulatory process and general changes in economic conditions. Investors should consult the Company's quarterly and annual filings with the Canadian and U.S. securities commissions for additional information on risks and uncertainties relating to the forward-looking statements. Investors are cautioned not to rely on these forward-looking statements. The Company does not undertake to update these forward-looking statements. We disclaim any obligation to update any su
'/>"/>

SOURCE AETERNA ZENTARIS INC.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. AEterna Zentaris completes management team with the appointment of Chief Medical Officer
2. AEterna Zentaris to Present at Upcoming UBS Global Life Sciences Conference in New York
3. AEterna Zentaris Announces Outcome of Managements Strategic Review
4. AEterna Zentaris to Further Develop Three Follow-up Multi-targeted Cytotoxic Candidates to AEZS-112 as Potential Novel Cancer Treatment
5. AEterna Zentaris Reports First Patients Treated with Anti-Cancer Compound AEZS-108 in Phase 2 Trial in Ovarian and Endometrial Cancers
6. AEterna Zentaris to Present at the Upcoming Roth Capital Partners 20th Annual OC Growth Stock Conference in Dana Point, California
7. Aeterna Zentaris to Announce Fourth Quarter and Full-Year 2007 Financial and Operating Results on March 5, 2008
8. AEterna Zentaris Announces the Departure of SVP, Administrative and Legal Affairs
9. AEterna Zentaris and Paladin Labs Announce Sale and Purchase of Miltefosine Rights
10. Aeterna Zentaris Reports Fourth Quarter and Full-Year 2007 Financial and Operating Results
11. Aeterna Zentaris Begins Second Phase 3 Trial of Cetrorelix for Benign Prostatic Hyperplasia

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/18/2009)...D, Calif., Nov. 18 Sanga...day that data from the University of Pennsylvania ...gamo,s zinc finger nuclease (ZFN) based product, S...turely disclosed on the internet. ,, Data were ... Pennsylvania School of Medicine from a single sub...
(Date:11/18/2009)...Calif., Nov. 18 Masimo...ry(TM) and Measure-Through Motion and Low-Perfusio...e-based Uni.H.A., one of the largest healthcare Gr...signed a multi-year purchasing agreement for "gold...e agreement offers preferred contract pricing to U...
(Date:11/18/2009)... YORK, Nov. 18 Reportlinker.com an...able in its catalogue. ,, Biotechnology Reage.../www.reportlinker.com/p0164375/Biotechnology-Reage...prnewswire&utm_medium=pr&utm_campaign=prne...complex chemical compounds used in a range of biot...
(Date:11/18/2009)... Promega Corporation and SwitchGear Genomics...otein interactions. , Mad... Corporation and SwitchGear Genomics announce a no...ions. Results of a study using the HaloCHIP™...trate the ability to correlate DNA binding events ...
Breaking Biology Technology:Sangamo BioSciences Provides Update on Phase 1 Safety Trial of SB-728-T for HIV/AIDS 2Uni.H.A. in France Signs Purchasing Agreement for Masimo SET(R) Pulse Oximetry Products 2Uni.H.A. in France Signs Purchasing Agreement for Masimo SET(R) Pulse Oximetry Products 3Uni.H.A. in France Signs Purchasing Agreement for Masimo SET(R) Pulse Oximetry Products 4Reportlinker Adds Biotechnology Reagents - A Global Market Perspective 2Reportlinker Adds Biotechnology Reagents - A Global Market Perspective 3Reportlinker Adds Biotechnology Reagents - A Global Market Perspective 4Reportlinker Adds Biotechnology Reagents - A Global Market Perspective 5Reportlinker Adds Biotechnology Reagents - A Global Market Perspective 6Reportlinker Adds Biotechnology Reagents - A Global Market Perspective 7Reportlinker Adds Biotechnology Reagents - A Global Market Perspective 8Promega and SwitchGear Publish Findings from Combined Technologies that Correlate Binding Events and Transcriptional Activity 2
...rints can reveal critical evidence, as well as an ...ed at Purdue University that detects trace amounts...nd in the prints. , The new technology also can d...y different individuals - a difficult task for cur... Graham Cooks, Purdue,s Henry Bohn Hass Distinguis...
...s have induced electrons in the nanocrystals of se...nto a smaller volume. This has the potential to im...of solar power. , "Slowing down the cooling of the...ld lead to a better infrared laser source," said P... Physics at the University of Chicago. "This, in t...
...ient,Pharmaceuticals, Inc. (Nasdaq: SVNT ) today ...Chief Executive Officer of Savient Pharmaceuticals...azard Capital Markets 5th,Annual Healthcare Confer...Tuesday, November 18, 2008 at,9:25 a.m. ET. The Co...w,York City November 18-19, 2008., Individuals ca...
Other Biology Technology:Fingerprints provide clues to more than just identity 2New research expected to improve laser devices and make photovoltaics more efficient 2Savient Pharmaceuticals to Present at the Lazard Capital Markets 5th Annual Healthcare Conference on November 18th 2
(Date:11/20/2009)...vited to contribute their abstracts to the World C...he largest global meeting devoted to all aspects o...ient care. The Congress will be held in Florence, ...tracts can be submitted online at http://www.iofw...bruary 4, 2010. , IOF and ESCEO are pleased to a...
(Date:11/20/2009)... Toxins in coal-tar-based sealcoats in parking lot...ccording to a USGS study. PAHs or polycyclic aro...il, coal and tar deposits, and can have toxic effe...d in house dust; however, the specific sources of ...ound that dust from indoor areas near parking lots...
(Date:11/20/2009)...om the production of flax shives, and generated fr...lated to those which engulf fields in spring, can ...sted by two studies carried out by Spanish and Dut...able and Sustainable Energy Reviews . , "These st...w, the production of bioethanol from two, as yet u...
Breaking Biology News(10 mins):Special sessions announced for World Congress on Osteoporosis 2010 - IOF WCO - ECCEO10 2Special sessions announced for World Congress on Osteoporosis 2010 - IOF WCO - ECCEO10 3From toxic dust and algae to ill winds from Africa 2From toxic dust and algae to ill winds from Africa 3From toxic dust and algae to ill winds from Africa 4From toxic dust and algae to ill winds from Africa 5Flax and yellow flowers can produce bioethanol 2Zipcar Wraps Up Month Long Program Reveals Results of the 2009 Low Car Diet 55127 1Zipcar Wraps Up Month Long Program Reveals Results of the 2009 Low Car Diet 55127 2Zipcar Wraps Up Month Long Program Reveals Results of the 2009 Low Car Diet 55127 3Zipcar Wraps Up Month Long Program Reveals Results of the 2009 Low Car Diet 55127 4Glow in the dark red blood cells made from human stem cells 9680 1Warner Chilcott Acquires P 26Gs Global Pharmaceuticals Business 55124 1Warner Chilcott Acquires P 26Gs Global Pharmaceuticals Business 55124 2Warner Chilcott Acquires P 26Gs Global Pharmaceuticals Business 55124 3Warner Chilcott Acquires P 26Gs Global Pharmaceuticals Business 55124 4Warner Chilcott Acquires P 26Gs Global Pharmaceuticals Business 55124 5Warner Chilcott Acquires P 26Gs Global Pharmaceuticals Business 55124 6Warner Chilcott Acquires P 26Gs Global Pharmaceuticals Business 55124 7Warner Chilcott Acquires P 26Gs Global Pharmaceuticals Business 55124 8
...f Singapore (GIS) and the Anhui Medical University...ant role in the development of psoriasis, a common... Human Genetics Group Leader and Associate Prof. L...09 in the journal Nature Genetics . , Studying g...hort of patients with psorasis and healthy control...
...cial skin and muscles around the mouth plays an im...ech are made, but also in the way they are heard a...atories, a Yale-affiliated research laboratory. ,...in how you ,hear, what you hear," said first autho...When, Ito and his colleagues used a robotic device...
...lobal warming is speeding up the mortality of tree...viding some of the data to prove it. , Pete Ful, ...ry and a director of the university,s Ecological R... Increase of Tree Mortality Rates in the Western U...an. 23 issue of Science journal. , The study, l...
Other Biology News:Compromised skin barrier function plays a role in psorasis development 2Feeling your words: Hearing with your face 2NAU research ties tree mortality trends to climate warming 2
SigmaScreen APS Coated Slides for Microarrays from Sigma-Aldrich
Bromophenol Blue sodium salt from Sigma-Aldrich
DAPI from KPL
LV-2080 Solvent Switching Valve from JASCO
Biology Products: